Shoulder Innovations, Inc. (SI)
NYSE: SI · Real-Time Price · USD
14.91
-0.10 (-0.63%)
Sep 12, 2025, 10:02 AM EDT - Market open
Shoulder Innovations Market Cap
Shoulder Innovations has a market cap or net worth of $303.47 million as of September 12, 2025.
Market Cap
303.47M
Enterprise Value
280.71M
1-Year Change
n/a
Ranking
Category
Stock Price
14.91
Market Cap Chart
Since the IPO on July 31, 2025, Shoulder Innovations's market cap has increased from $298.85M to $303.47M, an increase of 1.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 305.40M | 17.74% |
Sep 10, 2025 | 259.39M | -14.95% |
Sep 9, 2025 | 304.99M | -3.72% |
Sep 8, 2025 | 316.78M | 7.07% |
Sep 5, 2025 | 295.86M | -2.69% |
Sep 4, 2025 | 304.03M | 1.46% |
Sep 3, 2025 | 299.65M | -6.12% |
Sep 2, 2025 | 319.17M | 8.10% |
Aug 29, 2025 | 295.27M | 0.07% |
Aug 28, 2025 | 295.07M | -6.09% |
Aug 27, 2025 | 314.19M | 5.63% |
Aug 26, 2025 | 297.46M | -0.60% |
Aug 25, 2025 | 299.25M | 18.17% |
Aug 22, 2025 | 253.23M | 4.18% |
Aug 21, 2025 | 243.07M | 0.83% |
Aug 20, 2025 | 241.07M | -2.73% |
Aug 19, 2025 | 247.85M | -13.19% |
Aug 18, 2025 | 285.50M | 1.70% |
Aug 15, 2025 | 280.72M | 2.40% |
Aug 14, 2025 | 274.15M | 4.72% |
Aug 13, 2025 | 261.79M | -0.08% |
Aug 12, 2025 | 261.99M | 8.23% |
Aug 11, 2025 | 242.07M | -2.10% |
Aug 8, 2025 | 247.25M | 2.06% |
Aug 7, 2025 | 242.27M | -6.89% |
Aug 6, 2025 | 260.20M | -7.77% |
Aug 5, 2025 | 282.12M | -0.77% |
Aug 4, 2025 | 284.31M | 0.14% |
Aug 1, 2025 | 283.91M | -5.00% |
Jul 31, 2025 | 298.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.45B |
Johnson & Johnson | 423.36B |
AbbVie | 373.87B |
UnitedHealth Group | 314.07B |
AstraZeneca | 250.26B |
Novo Nordisk | 244.96B |
Novartis AG | 244.56B |
Abbott Laboratories | 225.15B |